 This has led to an enhanced understanding of vector host interactions and a new generation of vectors with substantially improved performance profiles beyond that provided from the original 6 AAV isolates.More recently, Wilson’s laboratory has used AAV to accomplish successful "in vivo" genome editing.As of 2018, his laboratory’s translational research portfolio included more than 30 orphan disease programs.